Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 8Unknown 3Terminated 2Withdrawn 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Flushing 1Esophageal Neoplasms 1Cardiovascular Diseases 1Alzheimer Disease 1

Interventions

Oxaliplatin 87Bevacizumab 68Capecitabine 65Fluorouracil 48tislelizumab 41Gemcitabine 41Drug Therapy 41Leucovorin 38sintilimab 36Irinotecan 35lenvatinib 28Cisplatin 27HMPL-013 24S 1 (combination) 23camrelizumab 22Immune Checkpoint Inhibitors 21irinotecan sucrosofate 20apatinib 20Surgical Procedures, Operative 20Radiotherapy 20Injections 20Paclitaxel 19130-nm albumin-bound paclitaxel 19toripalimab 18Folfox protocol 17pembrolizumab 15Immunotherapy 15Cetuximab 15Specimen Handling 14Radiosurgery 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Ethanol × Gastrointestinal × Clear all
NCT07392775 2026-02-06

ALDH2 Genetic Testing in East Asian Community

Northwestern University

Phase NA Not yet recruiting
100 enrolled
Gastrointestinal

Alzheimer Disease, Cardiovascular Diseases, Esophageal Neoplasms, Flushing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡